Biocore® µ-BCR-ABL1 p230 PCR kit – quantity

Biocore® µ-BCR-ABL1 p230 Quantitative — RT-PCR-RF test system for the quantitative determination of the e19-a2 transcript of the BCR-ABL1 gene translocation product (Philadelphia chromosome, p230 type) from the Ukrainian developer Biocore Technology. The kit is intended for the diagnosis and quantitative determination (monitoring) of a rare neutrophilic variant of chronic myeloid leukaemia (CML-N / p230-positive CML), which is caused by the expression of the e19-a2 transcript (<1% of all cases of BCR-ABL1-positive conditions). Registered name: ‘Biocore® µ-BCR-ABL1 p230 Quantity’ Diagnostic Kit for the quantification of the e19-a2 transcript of the BCR-ABL1 gene translocation using real-time RT-PCR Catalogue number: SM-µ-BCR-ABL1 601-100

Product expert helpline: please call +380444927270 (extension 3463).